Working… Menu

Safety and Efficacy of the LVIS and LVIS JR Devices in the Endovascular Treatment of Intracranial Aneurysms

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03553771
Recruitment Status : Recruiting
First Posted : June 12, 2018
Last Update Posted : October 29, 2018
Information provided by (Responsible Party):
Microvention-Terumo, Inc.

Brief Summary:
A French, multicenter, prospective, observational, "real life" assessment of the safety and efficacy of LVIS and LVIS JR devices in the treatment of intracranial aneurysms

Condition or disease Intervention/treatment
Intracranial Aneurysm Device: LVIS and LVIS JR

Detailed Description:

This is a multicenter observational study. Treatment and follow-up visits will be done as per standard of care.

The purpose of this study is to collect data on safety of the devices used since the French reimbursement.

130 patients will be enrolled over an 18-month recruitment period. All patients will be followed for at least 12 months.

Layout table for study information
Study Type : Observational
Estimated Enrollment : 130 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: A French, Multicenter, Prospective, Observational, "Real Life" Assessment of the Safety and Efficacy of the Low Profile Visualized Intraluminal Support (LVIS and LVIS JR) Devices in the Treatment of Intracranial Aneurysms
Actual Study Start Date : February 7, 2018
Estimated Primary Completion Date : April 1, 2021
Estimated Study Completion Date : April 1, 2022

Resource links provided by the National Library of Medicine

Intervention Details:
  • Device: LVIS and LVIS JR
    Braided coil assist stents used for aneurysm embolization
    Other Name: Low Profile Visualized Intraluminal Support

Primary Outcome Measures :
  1. Mortality Rate [ Time Frame: 1 year ]
  2. Morbidity Rate [ Time Frame: 1 year ]
    Number of adverse events with clinical impact related to the procedure and/or the procedure

Secondary Outcome Measures :
  1. Clinical effectiveness [ Time Frame: 1 year ]
    Number of patients with mRS>2

  2. Anatomical effectiveness [ Time Frame: 1 year ]
    Number of patients with complete occlusion of the treated aneurysm

  3. Retreatment rate [ Time Frame: 1 year ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
All patients with ruptured or not ruptured intracranial aneurysms treated with LVIS or LVIS Jr stent

Inclusion Criteria:

  • Patient with an intracranial aneurysm for which an endovascular treatment is indicated with the device LVIS or LVIS JR, either scheduled or emergency (" Bail-out stenting ")
  • Patient or patient's legally authorized representative has been informed about the study and does not oppose the collection of his/her personal data

Exclusion Criteria:

  • None

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT03553771

Layout table for location contacts
Contact: Laurence Bousquet +33139217746
Contact: Patricia Boyer +33139217746

Layout table for location information
CHU Pellgrin Recruiting
Bordeaux, France
Contact: Florent Maire   
Principal Investigator: Xavier Barreau, MD         
CHU Caen Recruiting
Caen, France
Principal Investigator: Charlotte Barbier, MD         
CHU Gabriel Montpied Recruiting
Clermont-Ferrand, France
Principal Investigator: Emmanuel Chabert, MD         
CHU Michallon Recruiting
Grenoble, France
Principal Investigator: Florence Tahon, MD         
Hôpital Bicêtre Recruiting
Le Kremlin-Bicêtre, France
Principal Investigator: Laurent Spelle, MD         
CHU Limoges Recruiting
Limoges, France
Principal Investigator: Charbel Mounayer, Prof.         
CHU de Lyon Not yet recruiting
Lyon, France
Principal Investigator: Omer Eker, MD         
Hôpital Clairval Recruiting
Marseille, France
Principal Investigator: Olivier Levrier, Prof.         
Hôpital de la Timone Recruiting
Marseille, France
Principal Investigator: Hervé Brunel, MD         
Hôpital Gui de Chauliac Recruiting
Montpellier, France
Principal Investigator: Vincent Costalat, Prof.         
Hôpital Central de Nancy Recruiting
Nancy, France
Principal Investigator: Anne-Laure Derelle, MD         
Hôpital Pasteur 2 Recruiting
Nice, France
Principal Investigator: Jacques Sedat, MD         
Hôpital Lariboisière Recruiting
Paris, France
Principal Investigator: Emmanuel Houdart, Prof.         
Hôpital Pitié-Salpêtrière Recruiting
Paris, France
Principal Investigator: Nader Sourour, MD         
Principal Investigator: Frédéric Clarençon, Prof.         
La Fondation Rothschild Recruiting
Paris, France
Principal Investigator: Michel Piotin, MD         
Hôpital Maison Blanche Recruiting
Reims, France
Principal Investigator: Laurent Pierot, Prof.         
Hôpital Nord Recruiting
Saint-Étienne, France
Principal Investigator: Mohamed Aggour, MD         
Hôpital Foch Not yet recruiting
Suresnes, France
Principal Investigator: Arturo Consoli, MD         
Hôpital d'instruction des Armées Saint-Anne Recruiting
Toulon, France
Principal Investigator: Charles Arteaga, Prof.         
Hôpital Purpan Recruiting
Toulouse, France
Principal Investigator: Christophe Cognard, Prof.         
Hôpital Bretonneau Recruiting
Tours, France
Principal Investigator: Denis Herbreteau, Prof.         
Sponsors and Collaborators
Microvention-Terumo, Inc.
Layout table for investigator information
Principal Investigator: Michel Piotin, MD Fondation Rothschild, Paris, France
Principal Investigator: Charbel Mounayer, Prof. CHU de Limoges, France

Layout table for additonal information
Responsible Party: Microvention-Terumo, Inc. Identifier: NCT03553771     History of Changes
Other Study ID Numbers: LEPI
First Posted: June 12, 2018    Key Record Dates
Last Update Posted: October 29, 2018
Last Verified: October 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Microvention-Terumo, Inc.:
Additional relevant MeSH terms:
Layout table for MeSH terms
Intracranial Aneurysm
Vascular Diseases
Cardiovascular Diseases
Intracranial Arterial Diseases
Cerebrovascular Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases